Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery

Chest pain is one of the hallmarks of myocardial ischemia (angina pectoris). Exact mechanisms responsible for the production of ischemia-induced pain are not clear. 1 A prevailing hypothesis postulates the activation of peripheral nociceptive receptors by substances originating in the ischemic myoca...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 70; no. 20; pp. 1621 - 1623
Main Authors Eldar, Michael, Hollander, Gerald, Schulhoff, Nancy, Ohlstein, Elliot, Greengart, Alvin, Lichstein, Edgar, Shani, Jacob
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 15.12.1992
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chest pain is one of the hallmarks of myocardial ischemia (angina pectoris). Exact mechanisms responsible for the production of ischemia-induced pain are not clear. 1 A prevailing hypothesis postulates the activation of peripheral nociceptive receptors by substances originating in the ischemic myocardium. 2–4 Several investigators have suggested that bradykinin, one of the most potent natural algesic substances, may be responsible for anginal pain. 5,6 Kimura et al 7 found that coronary ligation in the dog induces a rapid increase in the coronary sinus level of bradykinin. The relation of bradykmin to myocardial ischemic pain in humans has not been previously reported. We studied the plasma bradykinin level in the great cardiac vein during transient myocardial ischemia induced by balloon angioplasty of the left anterior descending coronary artery in humans.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9149
1879-1913
DOI:10.1016/0002-9149(92)90472-B